These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 13733613)

  • 1. The use of factor VIII freed from fibrinogen in the treatment of haemophilic patients.
    PAVLOVSKY A; SIMONETTI C; CASILLAS G; BERGNA LJ; ANDINO A; BACHMANN AE
    Br J Haematol; 1961 Jul; 7():365-72. PubMed ID: 13733613
    [No Abstract]   [Full Text] [Related]  

  • 2. Antihemophilic A factor (factor VIII) and fibrinogen in human blood. A study on the question of a closer correlation between the levels of the two factors.
    EGEBERG O
    Scand J Clin Lab Invest; 1962; 14():230-4. PubMed ID: 13889401
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preparation of a human plasmatic fraction rich in factor VIII (antihemophilic A) and poor in fibrinogen].
    NIEMETZ J; WEILLAND C; SOULIER JP
    Nouv Rev Fr Hematol; 1961; 1():880-6. PubMed ID: 14479667
    [No Abstract]   [Full Text] [Related]  

  • 4. [Separation of fibrinogen and of the antihemophilic factor A].
    SOULIER JP; GOBBI F; LARRIEU MJ
    Rev Hematol; 1957; 12(4):481-96. PubMed ID: 13518868
    [No Abstract]   [Full Text] [Related]  

  • 5. A study of the separation of fibrinogen and antihemophilic factor (AHF) in canine, porcine, and human plasmas.
    WAGNER RH; RICHARDSON BA; BRINKHOUS KM
    Thromb Diath Haemorrh; 1958 Apr; 1(1):1-8. PubMed ID: 13569420
    [No Abstract]   [Full Text] [Related]  

  • 6. ANTIHEMOPHILIC FACTOR: ITS PRESENCE IN FIBRINOGEN, ASSAY PROBLEMS AND THE STABILITY OF LYOPHILIZED AHF-FIBRINOGEN PREPARATIONS.
    BAUMGARTEN W; SANDERS BE; BELKIN BD; PAGENKEMPER FE; ALBERS WG; CIMINERA JL
    Thromb Diath Haemorrh; 1963 Jul; 143():354-67. PubMed ID: 14081259
    [No Abstract]   [Full Text] [Related]  

  • 7. Enzyme studies on human blood. VIII. The effect of fibrinogen concentration on the thrombin clotting time.
    SHINOWARA GY; ROSENFELD L
    J Lab Clin Med; 1951 Feb; 37(2):303-10. PubMed ID: 14814357
    [No Abstract]   [Full Text] [Related]  

  • 8. [The different action of bovine and human factor VIII (anti-haemophilic globulin) on factor X consumption during coagulation].
    Mayer G; Mayer S; Waitz R
    Rev Fr Etud Clin Biol; 1969 Dec; 14(10):1028-31. PubMed ID: 5377890
    [No Abstract]   [Full Text] [Related]  

  • 9. EFFECT OF FIBRINOGEN ON THE AGGREGATION OF PLATELETS BY ADENOSINE DIPHOSPHATE.
    CROSS MJ
    Thromb Diath Haemorrh; 1964 Dec; 12():524-7. PubMed ID: 14254709
    [No Abstract]   [Full Text] [Related]  

  • 10. [PRESERVATION OF ANTIHEMOPHILIC GLOBULIN IN PRESERVED BLOOD].
    RUTBERG RA; MALLER AR; ABDULLAEV GM
    Probl Gematol Pereliv Krovi; 1963 Sep; 8():19-23. PubMed ID: 14119758
    [No Abstract]   [Full Text] [Related]  

  • 11. An artificial 'haemophilic' plasma for one-stage factor-VIII assay.
    Chantarangkul V; Ingram GI; Thorn MB; Darby SC
    Br J Haematol; 1978 Nov; 40(3):471-88. PubMed ID: 107960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response of coagulation and anti-coagulant factors of elite athletes following acute resistance and high-intensity interval training.
    Karampour S; Gaeini AA
    J Sports Med Phys Fitness; 2018; 58(1-2):120-126. PubMed ID: 28474867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MODERN ASPECTS OF THE TREATMENT OF HEMOPHILIA. III.
    VANCREVELD S; MOCHTAR IA; KOPPE JG
    Can Med Assoc J; 1964 May; 90(22):1248-9. PubMed ID: 14158954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MODERN ASPECTS OF THE TREATMENT OF HEMOPHILIA. II.
    VAN CREVELD ; MOCHTAR IA; KOPPE JG
    Can Med Assoc J; 1963 Nov; 89(18):911-4. PubMed ID: 14052972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of platelet factor 1 and platelet fibrinogen to plasma.
    JOHNSON SA; MONTO RW; CALDWELL MJ
    J Appl Physiol; 1958 Nov; 13(3):406-10. PubMed ID: 13587423
    [No Abstract]   [Full Text] [Related]  

  • 16. Modern aspects of the treatment of hemophilia.
    van CREVELD ; MOCHTAR IA
    Can Med Assoc J; 1962 Nov; 87(19):993-7. PubMed ID: 14023829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [EXPERIMENTS CONCERNING FACTOR 8. LONGEVITY OF FACTOR 8 IN VIVO AND VITRO AND THE SUBFRACTIONATION OF FIBRINOGEN SAMPLES FROM 2 DONORS].
    MOCHTAR IA; KOPPE JG; STIBBE J
    Maandschr Kindergeneeskd; 1964 Jul; 32():440-5. PubMed ID: 14228685
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE SUPPLY OF PERSONALLY PREPARED PLASMA FRACTIONS IN HEMOPHILIA A].
    GAERISCH F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1963; 81():148-55. PubMed ID: 14165084
    [No Abstract]   [Full Text] [Related]  

  • 19. THE IMPORTANCE OF PLASMA-FRACTION I ACCORDING TO COHN IN SURGICAL DISEASES.
    IMDAHL H; EGLI H
    Bibl Haematol; 1964; 19():151-5. PubMed ID: 14266988
    [No Abstract]   [Full Text] [Related]  

  • 20. Fibrinogen derived inhibitors of blood coagulation.
    KOWALSKI E
    Thromb Diath Haemorrh; 1960; 4(Suppl)():211-23. PubMed ID: 13753710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.